| Clinical data | |
|---|---|
| Trade names | Topiloric, Uriadec |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C13H8N6 |
| Molar mass | 248.249 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Topiroxostat (INN; trade namesTopiloric,Uriadec) is a drug for the treatment ofgout andhyperuricemia.[1] It was approved for use in Japan in June 2013.[1]
Topiroxostat is axanthine oxidase inhibitor which reduces serumurate levels.[2]
Thisdrug article relating to themusculoskeletal system is astub. You can help Wikipedia byexpanding it. |